Questions have been raised after big political names and Parastatals names that were mentioned in the 7.8 billion Kenya Medical Supplies Authority (KEMSA) Covid-19 investigation by the Parliament were spared by a report released last week.
The big Parastatal Names include Accenture Kenya, Gadlab Suppliers, Meraky Healthcare, Steplabs Medical Services, Wallabis Ventures, Shop and Buy and Kilig Limited Directors.
The firms named above, their directors and KEMSA officials face charges related to procurement and payment of the supplies. More than 102 firms that had traded with KEMSA during the questioning had openly admitted violating the law.
Kilig Limited Directors which was also spared off by the report is closely connected to Jubilee Vice Chairman David Murathe. David Murathe has denied being linked to the Parastatal which nearly bagged a sh 4 billion tender even without experience in drugs and medical kits.
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More